Practice Point Communications

June is Myasthenia Gravis awareness month 💙 MG is a rare neuromuscular disease affecting an estimated 75,000–100,000 Americans. While treatment options exist, the complexity of this condition often requires individualized care plans tailored to each patient's needs.

Raising awareness of rare diseases like MG is essential to advancing earlier diagnosis, improving patient outcomes, and supporting ongoing research.

Watch Dr. James Howard deliver a 20-minute update on the most clinically relevant advances presented in Chicago, IL at AAN 2026 at www.practicepointcme.com/CMEHome/advancing-myasthenia-gravis-care-emerging-insights-from-aan-2026 🔗